dichloroacetic acid methyl ester
(1R,2R)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol
chloramphenicol
Conditions | Yield |
---|---|
In methanol at 23 - 40℃; for 9h; Inert atmosphere; | 97% |
at 90℃; for 1h; | 80% |
Amidation; | 74% |
2,2-dichloro-N-[1-hydroxymethyl-2-methoxy-2-(4-nitrophenyl)-ethyl]-acetamide
chloramphenicol
Conditions | Yield |
---|---|
With boron tribromide In dichloromethane at -20℃; for 12h; | 80% |
chloramphenicol
Conditions | Yield |
---|---|
With sodium tetrahydroborate In methanol at 0℃; for 1h; Inert atmosphere; | 80% |
dichloroacetic acid methyl ester
(4R,5R)-5-(4-nitrophenyl)-4-hydroxymethyl-1,3-oxazolidin-2-one
chloramphenicol
Conditions | Yield |
---|---|
Stage #1: (4R,5R)-5-(4-nitrophenyl)-4-hydroxymethyl-1,3-oxazolidin-2-one With sodium hydroxide In methanol; water at 25℃; Stage #2: dichloroacetic acid methyl ester at 90℃; for 3h; | 78% |
Stage #1: (4R,5R)-5-(4-nitrophenyl)-4-hydroxymethyl-1,3-oxazolidin-2-one With sodium hydroxide In water for 0.5h; Reflux; Stage #2: dichloroacetic acid methyl ester In water at 90℃; for 3h; | 70% |
(2S)-(2,2-dichloroacetylamino)-(3R)-hydroxy-3-(4-nitrophenyl)-propionic acid ethyl ester
chloramphenicol
Conditions | Yield |
---|---|
With sodium tetrahydroborate In methanol at 0℃; for 0.5h; | 74% |
Conditions | Yield |
---|---|
Stage #1: dichloroacetonitrile; (αR,2R)-α-(4-nitrophenyl)oxiranemethanol With sodium hydride In dichloromethane at 0 - 20℃; for 1h; Stage #2: With boron trifluoride diethyl etherate In dichloromethane at -78 - 20℃; for 3h; | 71% |
chloramphenicol
chloramphenicol
Conditions | Yield |
---|---|
With dimethylsulfide borane complex In tetrahydrofuran for 16h; Ambient temperature; | 70% |
dichloroacethyl chloride
(1R,2R)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol
chloramphenicol
Conditions | Yield |
---|---|
With dichloro-acetic acid und anschliessend mit wss.Aceton bei pH8-9; |
chloral hydrate
(1R,2R)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol
potassium cyanide
chloramphenicol
pentachloroacetone
(1R,2R)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol
chloramphenicol
Conditions | Yield |
---|---|
With 1,4-dioxane |
bis-dichloroacetyl-amine
(1R,2R)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol
chloramphenicol
Conditions | Yield |
---|---|
With ethanol |
dichloroacetyl-phosphorous acid diethyl ester
(1R,2R)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol
chloramphenicol
Conditions | Yield |
---|---|
With methanol | |
With ethyl acetate |
(1R,2R)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol
chloramphenicol
Conditions | Yield |
---|---|
With ethanol |
(1R,2R)-3-dichloroacetoxy-2-(2,2-dichloro-acetylamino)-1-(4-nitro-phenyl)-propan-1-ol
chloramphenicol
Conditions | Yield |
---|---|
With acetone |
Conditions | Yield |
---|---|
durch Chromatographie an einer Lactose-Saeule; | |
With chiral stationary phase derived from aminated silica gel, L-2-(p-toluenesulfonamido)-3-phenylpropionyl chloride and dendrimer In methanol; water at 25℃; Resolution of racemate; |
dichloroacetic acid-[(5R)-4c-(4-nitro-phenyl)-2-oxo-[1,3]dioxan-5r-ylamide]
chloramphenicol
Conditions | Yield |
---|---|
With hydrogenchloride |
dichloroacetic acid-[(5R)-4c-(4-nitro-phenyl)-2ξ-oxo-2λ4-[1,3,2]dioxathian-5r-ylamide]
chloramphenicol
Conditions | Yield |
---|---|
With hydrogenchloride |
(1R,2R)-2-(2,2-dichloro-acetylamino)-1-(4-nitro-phenyl)-3-nitryloxy-propan-1-ol
chloramphenicol
Conditions | Yield |
---|---|
With methanol; iron(II) ammonium sulfate | |
With aminosulfonic acid; water; iron(II) sulfate |
Conditions | Yield |
---|---|
ueber das O3-<3-Carboxy-propionyl>-Derivat; |
(R)-((R)-2-dichloromethyl-4,5-dihydro-oxazol-4-yl)-(4-nitro-phenyl)-methanol
chloramphenicol
Conditions | Yield |
---|---|
With acid Hydrolysis; |
threo (1R)-acetoxymethoxy-(2R)-dichloroacetamido-3-acetoxy-1-p-nitrophenylpropane
chloramphenicol
Conditions | Yield |
---|---|
With ammonium hydroxide In methanol |
Conditions | Yield |
---|---|
With borate buffer pH 7.5; lipase at 37℃; for 5h; Rate constant; also addition of β-cyclodextrin, chloramphenicol or palmitic acid, var. of polymorphic forms; |
Conditions | Yield |
---|---|
With borate buffer pH 7.5; lipase at 37℃; for 5h; Rate constant; also addition of chloramphenicol or palmitic acid, var. of polymorphic forms; |
chloramphenicol
Conditions | Yield |
---|---|
With tetrabutyl ammonium fluoride In tetrahydrofuran desilylation; |
chloramphenicol
Conditions | Yield |
---|---|
With methanol; iron(II) ammonium sulfate | |
With aminosulfonic acid; water; iron(II) sulfate | |
With methanol; iron(II) chloride |
chloramphenicol
Conditions | Yield |
---|---|
With methanol; iron(II) chloride |
chloramphenicol
Conditions | Yield |
---|---|
With sodium tetrahydroborate; ethyl acetate |
chloramphenicol
Conditions | Yield |
---|---|
With lithium aluminium tetrahydride; diethyl ether |
3-nitro-1-palmitoyl-1H-1,2,4-triazole
chloramphenicol
chloramphenicol Palmitate
Conditions | Yield |
---|---|
With triethylamine In tetrahydrofuran at 20℃; for 1h; regioselective reaction; | 100% |
chloramphenicol
chloramphenicol
Conditions | Yield |
---|---|
With 1H-imidazole In dichloromethane for 2h; | 99% |
With 1H-imidazole In N,N-dimethyl-formamide for 19h; Ambient temperature; | 95% |
With dmap; triethylamine In dichloromethane |
Conditions | Yield |
---|---|
With palmitic acid imprinted Thermomyces lanuginosus Lypozyme TL 100L lipase nanogel In acetonitrile at 20℃; for 48h; Temperature; Concentration; Reagent/catalyst; Green chemistry; Enzymatic reaction; regioselective reaction; | 99% |
With lipase encapsulated polyacrylamide nanogel In water; acetonitrile at 20℃; for 6h; Reagent/catalyst; Enzymatic reaction; | 99% |
With Novozym 435 In acetonitrile at 20℃; for 3h; Inert atmosphere; Enzymatic reaction; regioselective reaction; | 91% |
chloramphenicol
propionyl chloride
(1R,2R)-2-[(dichloroacetyl)amino]-1-(4-nitrophenyl)-3-(propanoyloxy)propyl propanoate
Conditions | Yield |
---|---|
With dmap; triethylamine In dichloromethane at 20℃; for 1h; Inert atmosphere; | 99% |
chloramphenicol
acetyl chloride
(1R,2R)-3-(acetyloxy)-2-[(dichloroacetyl)amino]-1-(4-nitrophenyl)propyl acetate
Conditions | Yield |
---|---|
With dmap; triethylamine In dichloromethane at 20℃; for 1h; Inert atmosphere; | 99% |
chloramphenicol
p-toluenesulfonyl chloride
Toluene-4-sulfonic acid (2R,3R)-2-(2,2-dichloro-acetylamino)-3-hydroxy-3-(4-nitro-phenyl)-propyl ester
Conditions | Yield |
---|---|
With pyridine for 2h; Ambient temperature; | 97% |
Conditions | Yield |
---|---|
With triethylamine In tetrahydrofuran | 96% |
chloramphenicol
ortho-xylenyl phosphoryl chloride
Conditions | Yield |
---|---|
With 1,2,2,6,6-pentamethylpiperidine; C15H12F6N2O In dichloromethane at 20℃; for 4h; Inert atmosphere; | 96% |
chloramphenicol
1,3-bis(2-hydroxy-3-chloropropyl)-6-methyluracil
Conditions | Yield |
---|---|
With potassium carbonate In methanol at 60℃; for 8h; | 95% |
chloramphenicol
[(1R,2R)-2-amino-1-(4-nitrophenyl)propane-1,3-diol] hydrochloride
Conditions | Yield |
---|---|
With hydrogenchloride In water for 2h; Heating; | 93% |
Multi-step reaction with 2 steps 1: pyridine; dioxane 2: HCl; diethyl ether; dioxane View Scheme | |
With hydrogenchloride Heating; |
n-dodecanoyl chloride
chloramphenicol
(1R,2R)-2-[(dichloroacetyl)amino]-3-(lauroyloxy)-1-(4-nitrophenyl)propyl laurate
Conditions | Yield |
---|---|
With dmap; triethylamine In dichloromethane at 20℃; for 1h; Inert atmosphere; | 93% |
vinyl caprate
chloramphenicol
(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl decanoate
Conditions | Yield |
---|---|
With Novozym 435 In acetonitrile at 20℃; for 3h; Inert atmosphere; Enzymatic reaction; regioselective reaction; | 92% |
With lipase cloned from Bacillus amyloliquefaciens In ethanol at 50℃; for 4h; Inert atmosphere; Enzymatic reaction; regioselective reaction; |
Conditions | Yield |
---|---|
With 1,2,2,6,6-pentamethylpiperidine; C15H12F6N2O In dichloromethane at 20℃; for 4h; Inert atmosphere; | 92% |
Conditions | Yield |
---|---|
In acetonitrile at 20℃; for 18h; Inert atmosphere; | 92% |
Conditions | Yield |
---|---|
With pyridine In N,N-dimethyl-formamide; toluene at -4 - 5℃; for 4.83333h; Solvent; | 91.9% |
With pyridine | |
With benzene | |
With benzene unter Zusatzt von Pyridin; |
chloramphenicol
acetic anhydride
(1R,2R)-3-(acetyloxy)-2-[(dichloroacetyl)amino]-1-(4-nitrophenyl)propyl acetate
Conditions | Yield |
---|---|
With pyridine at 0 - 20℃; | 91% |
With pyridine |
vinyl laurate
chloramphenicol
(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl laurate
Conditions | Yield |
---|---|
With Novozym 435 In acetonitrile at 20℃; for 4h; Inert atmosphere; Enzymatic reaction; regioselective reaction; | 91% |
With lipase cloned from Bacillus amyloliquefaciens In ethanol at 50℃; for 4h; Inert atmosphere; Enzymatic reaction; regioselective reaction; |
Conditions | Yield |
---|---|
In acetonitrile at 20℃; for 18h; Inert atmosphere; | 91% |
vinyl acetate
chloramphenicol
(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl acetate
Conditions | Yield |
---|---|
With Novozym 435 In acetonitrile at 20℃; for 3h; Inert atmosphere; Enzymatic reaction; regioselective reaction; | 90% |
With lipase cloned from Bacillus amyloliquefaciens In ethanol at 50℃; for 4h; Inert atmosphere; Enzymatic reaction; regioselective reaction; |
vinyl propionate
chloramphenicol
(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl propionate
Conditions | Yield |
---|---|
With immobilised Pseudomonas cepacia lipase PSL-C I In 1,4-dioxane at 30℃; for 6h; Inert atmosphere; Enzymatic reaction; regioselective reaction; | 90% |
With lipase cloned from Bacillus amyloliquefaciens In 1,4-dioxane; ethanol at 50℃; for 8h; Catalytic behavior; Solvent; Temperature; Time; Inert atmosphere; Enzymatic reaction; regioselective reaction; |
chloramphenicol
acetic anhydride
tert-butyldimethylsilyl chloride
(1R,2R)-3-((tert-butyldimethylsilyl)oxy)-2-(2,2-dichloroacetamido)-1-(4-nitrophenyl)propyl acetate
Conditions | Yield |
---|---|
Stage #1: chloramphenicol; tert-butyldimethylsilyl chloride With 1H-imidazole In dichloromethane at 25℃; for 0.5h; Stage #2: acetic anhydride With triethylamine In dichloromethane at 25℃; for 12h; | 90% |
chloramphenicol
acetone
dichloroacetic acid-[(5R)-2,2-dimethyl-4c-(4-nitro-phenyl)-[1,3]dioxan-5r-ylamide]
Conditions | Yield |
---|---|
With 4 A molecular sieve; Amberlyst A 15 In tetrahydrofuran for 24h; Ambient temperature; | 89.3% |
chloramphenicol
1,3-bis(2-hydroxy-3-chloropropyl)uracil
Conditions | Yield |
---|---|
With potassium carbonate In methanol at 60℃; for 8h; | 87% |
chloramphenicol
propionic acid anhydride
A
(1R,2R)-2-[(dichloroacetyl)amino]-1-(4-nitrophenyl)-3-(propanoyloxy)propyl propanoate
B
(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl propionate
Conditions | Yield |
---|---|
With pyridine; dmap In dichloromethane for 0.0833333h; | A 15% B 85% |
chloramphenicol
butyryl chloride
B
threo-(1R,2R)-1-(4-nitrophenyl)-2-(dichloroacetamido)-1,3-propanediol 3-butanoate
Conditions | Yield |
---|---|
With pyridine; dmap In dichloromethane for 0.0833333h; | A 15% B 85% |
chloramphenicol
meta-hydroxybenzaldehyde
2,2-Dichloro-N-[(4R,5R)-2-(3-hydroxy-phenyl)-4-(4-nitro-phenyl)-[1,3]dioxan-5-yl]-acetamide
Conditions | Yield |
---|---|
With 4 A molecular sieve; Amberlyst A 15 In tetrahydrofuran for 24h; Ambient temperature; | 82% |
succinic acid anhydride
chloramphenicol
threo-(1R,2R)-1-(4-nitrophenyl)-2-(dichloroacetamido)-1,3-propanediol 3-succinate
Conditions | Yield |
---|---|
With triethylamine In tetrahydrofuran at 0℃; Reagent/catalyst; | 81% |
In 1,4-dioxane at 20℃; for 24h; lipase; | 64% |
With 1,4-dioxane; pyridine |
chloramphenicol
n-decanoyl chloride
(1R,2R)-3-(decanoyloxy)-2-[(dichloroacetyl)amino]-1-(4-nitrophenyl)propyl decanoate
Conditions | Yield |
---|---|
With dmap; triethylamine In dichloromethane at 20℃; for 1h; Inert atmosphere; | 80% |
Reported in EPA TSCA Inventory. EPA Genetic Toxicology Program.
The Chloramphenicol, with the CAS registry number 56-75-7,is also known as 2,2-Dichloro-N-[2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide. It belongs to the product categories of Pharmaceuticals;API;Chiral Reagents;Pharmaceutical intermediate. Its EINECS number is 200-287-4. This chemical's molecular formula is C11H12Cl2N2O5 and molecular weight is 323.13. What's more,Its systematic name is Chloramphenicol.It is a White to grey-white crystalline powder which is an antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic.This chemical may cause cancer. when you use it ,you should avoid exposure - obtain special instructions before use. In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
Physical properties about Chloramphenicol are:
(1)ACD/LogP: 1.103; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 1.10; (4)ACD/LogD (pH 7.4): 1.10; (5)ACD/BCF (pH 5.5): 4.06; (6)ACD/BCF (pH 7.4): 4.05; (7)ACD/KOC (pH 5.5): 94.80; (8)ACD/KOC (pH 7.4): 94.75; (9)#H bond acceptors: 7; (10)#H bond donors: 3; (11)#Freely Rotating Bonds: 8; (12)Index of Refraction: 1.612; (13)Molar Refractivity: 72.559 cm3; (14)Molar Volume: 208.831 cm3; (15)Polarizability: 28.765 10-24cm3 ; (16)Surface Tension: 66.1240005493164 dyne/cm; (17)Density: 1.547 g/cm3; (18)Flash Point: 343.831 °C; (19)Enthalpy of Vaporization: 99.983 kJ/mol; (20)Boiling Point: 644.913 °C at 760 mmHg; (21)Vapour Pressure: 0 mmHg at 25°C.
You can still convert the following datas into molecular structure:
(1)SMILES:c1cc(ccc1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-];
(2)Std. InChI:InChI=1S/C11H12Cl2N2O5/c12-10(13)11(18)14-8(5-16)9(17)6-1-3-7(4-2-6)15(19)20/h1-4,8-10,16-17H,5H2,(H,14,18)/t8-,9-/m1/s1;
(3)Std. InChIKey:WIIZWVCIJKGZOK-RKDXNWHRSA-N.
Uses of Chloramphenicol:
Chloramphenicol may be used as a second-line agent in the treatment of tetracycline-resistant cholera. Because of its excellent CSF penetration (far superior to any of the cephalosporins), chloramphenicol remains the first choice treatment for staphylococcal brain abscesses. It is also useful in the treatment of brain abscesses due to mixed organisms or when the causative organism is not known. Chloramphenicol has been used in the U.S. in the initial empirical treatment of children with fever and a petechial rash. It has recently been discovered to be a life saving cure for chytridiomycosis in amphibians.
The toxicity data of Chloramphenicol are as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
child | TDLo | unreported | 250mg/kg/10D (250mg/kg) | BLOOD: CHANGES IN BONE MARROW NOT INCLUDED ABOVE BLOOD: HEMORRHAGE LIVER: OTHER CHANGES | Clinical Pediatrics Vol. 14, Pg. 499, 1975. |
dog | LD | intramuscular | > 101mg/kg (101mg/kg) | Journal of Clinical Investigation. Vol. 28, Pg. 943, 1949. | |
dog | LD | oral | > 300mg/kg (300mg/kg) | Journal of Clinical Investigation. Vol. 28, Pg. 943, 1949. | |
dog | LDLo | intravenous | 150mg/kg (150mg/kg) | LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION | Journal of Bacteriology. Vol. 55, Pg. 425, 1948. |
guinea pig | LD50 | intravenous | 560mg/kg (560mg/kg) | Farmaco, Edizione Scientifica. Vol. 9, Pg. 21, 1954. | |
guinea pig | LD50 | oral | 500mg/kg (500mg/kg) | Farmaco, Edizione Scientifica. Vol. 10, Pg. 3, 1955. | |
infant | LDLo | intravenous | 30mg/kg/3D-I (30mg/kg) | CARDIAC: CARDIAC OUTPUT VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION | Journal of Pediatrics. Vol. 103, Pg. 487, 1983. |
infant | LDLo | unreported | 200mg/kg/4D-I (200mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE" BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BLOOD: EOSINOPHILIA | Lancet. Vol. 1, Pg. 555, 1986. |
infant | TDLo | intramuscular | 250mg/kg/2D (250mg/kg) | VASCULAR: CHANGE IN PLASMA OR BLOOD VALUME | New England Journal of Medicine. Vol. 262, Pg. 787, 1960. |
infant | TDLo | oral | 440mg/kg (440mg/kg) | JAMA, Journal of the American Medical Association. Vol. 234, Pg. 149, 1975. | |
infant | TDLo | oral | 440mg/kg (440mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) GASTROINTESTINAL: OTHER CHANGES | JAMA, Journal of the American Medical Association. Vol. 234, Pg. 149, 1975. |
mouse | LD50 | intraperitoneal | 1100mg/kg (1100mg/kg) | Dissertationes Pharmaceuticae. Vol. 14, Pg. 21, 1962. | |
mouse | LD50 | intravenous | 110mg/kg (110mg/kg) | BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Journal of Clinical Investigation. Vol. 28, Pg. 943, 1949. |
mouse | LD50 | oral | 1500mg/kg (1500mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 5, Pg. 1, 1955. | |
mouse | LD50 | subcutaneous | 400mg/kg (400mg/kg) | "Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 493, 1978. | |
rabbit | LD50 | intravenous | 117mg/kg (117mg/kg) | Journal of Clinical Investigation. Vol. 28, Pg. 943, 1949. | |
rat | LD50 | intraperitoneal | 1811mg/kg (1811mg/kg) | Toxicology and Applied Pharmacology. Vol. 18, Pg. 185, 1971. | |
rat | LD50 | intravenous | 171mg/kg (171mg/kg) | Journal of Clinical Investigation. Vol. 28, Pg. 943, 1949. | |
rat | LD50 | oral | 2500mg/kg (2500mg/kg) | Farmaco, Edizione Scientifica. Vol. 10, Pg. 3, 1955. | |
rat | LD50 | subcutaneous | 5gm/kg (5000mg/kg) | GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Toxicology and Applied Pharmacology. Vol. 9, Pg. 445, 1966. |
women | LDLo | oral | 400mg/kg (400mg/kg) | BEHAVIORAL: COMA LUNGS, THORAX, OR RESPIRATION: CYANOSIS VASCULAR: SHOCK | JAMA, Journal of the American Medical Association. Vol. 234, Pg. 149, 1975 |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View